Prognostic value of systemic inflammation response index in cervical cancer: a meta-analysis

The value of systemic inflammation response index (SIRI) in predicting cervical cancer (CC) prognosis has been evaluated, but the conclusions were debated. By performing a meta-analysis, this study sought to establish the accurate prognostic relevance of SIRI for CC. The study aimed to determine the effect of SIRI on predicting CC overall survival (OS) and progression-free survival (PFS) by HRs with 95%CIs. This work incorporated seven studies with 1271 patients enrolled. Based on our combined data, elevated SIRI exhibited remarkable relation to dismal OS (HR = 2.58, 95%CI = 1.75–3.79, p < 0.001) and worse PFS (HR = 1.88, 95%CI 1.33–2.66, p < 0.001) in CC. In addition, higher SIRI was significantly associated with advanced FIGO stage (OR = 1.71, 95%CI = 1.18–2.50, p = 0.005) and high-grade histology (OR = 1.63, 95%CI = 1.15–2.32, p = 0.006) of CC. Nonetheless, SIRI was not related to age, lymphovascular invasion (LVSI), tumor size, tumor invasion depth, pathological type, or lymph node (LN) metastasis. This meta-analysis revealed that higher SIRI is significantly related to impaired OS and poor PFS of CC cases. Furthermore, higher SIRI is also significant correlated to advanced FIGO stage and poor tumor differentiation of CC. Cervical cancer (CC) is the fourth most common cancer among women globally.Identifying novel and reliable biomarkers is crucial to improving survival outcomes for patients with CC.The systemic inflammation response index (SIRI) is used to assess systemic inflammation.This meta-analysis reveals that higher SIRI is significantly related to impaired OS and poor PFS of CC cases.Higher SIRI was significantly associated with advanced FIGO stage and high-grade histology of CC. Cervical cancer (CC) is the fourth most common cancer among women globally. Identifying novel and reliable biomarkers is crucial to improving survival outcomes for patients with CC. The systemic inflammation response index (SIRI) is used to assess systemic inflammation. This meta-analysis reveals that higher SIRI is significantly related to impaired OS and poor PFS of CC cases. Higher SIRI was significantly associated with advanced FIGO stage and high-grade histology of CC.

Publication Details

Journal
Figshare
Published
2025-01-01
DOI
https://doi.org/10.6084/m9.figshare.29487817
Primary Topic
Advanced Combinatorial Mathematics
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prognostic value of systemic inflammation response index in cervical cancer: a meta-analysis

Figshare
Advanced Combinatorial Mathematics
article

Prognostic value of systemic inflammation response index in cervical cancer: a meta-analysis

article en

Abstract

The value of systemic inflammation response index (SIRI) in predicting cervical cancer (CC) prognosis has been evaluated, but the conclusions were debated. By performing a meta-analysis, this study sought to establish the accurate prognostic relevance of SIRI for CC. The study aimed to determine the effect of SIRI on predicting CC overall survival (OS) and progression-free survival (PFS) by HRs with 95%CIs. This work incorporated seven studies with 1271 patients enrolled. Based on our combined data, elevated SIRI exhibited remarkable relation to dismal OS (HR = 2.58, 95%CI = 1.75–3.79, p < 0.001) and worse PFS (HR = 1.88, 95%CI 1.33–2.66, p < 0.001) in CC. In addition, higher SIRI was significantly associated with advanced FIGO stage (OR = 1.71, 95%CI = 1.18–2.50, p = 0.005) and high-grade histology (OR = 1.63, 95%CI = 1.15–2.32, p = 0.006) of CC. Nonetheless, SIRI was not related to age, lymphovascular invasion (LVSI), tumor size, tumor invasion depth, pathological type, or lymph node (LN) metastasis. This meta-analysis revealed that higher SIRI is significantly related to impaired OS and poor PFS of CC cases. Furthermore, higher SIRI is also significant correlated to advanced FIGO stage and poor tumor differentiation of CC. Cervical cancer (CC) is the fourth most common cancer among women globally.Identifying novel and reliable biomarkers is crucial to improving survival outcomes for patients with CC.The systemic inflammation response index (SIRI) is used to assess systemic inflammation.This meta-analysis reveals that higher SIRI is significantly related to impaired OS and poor PFS of CC cases.Higher SIRI was significantly associated with advanced FIGO stage and high-grade histology of CC. Cervical cancer (CC) is the fourth most common cancer among women globally. Identifying novel and reliable biomarkers is crucial to improving survival outcomes for patients with CC. The systemic inflammation response index (SIRI) is used to assess systemic inflammation. This meta-analysis reveals that higher SIRI is significantly related to impaired OS and poor PFS of CC cases. Higher SIRI was significantly associated with advanced FIGO stage and high-grade histology of CC.

Figshare
No poverty
Openalex Percentile: Top 46%
Advanced Combinatorial Mathematics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.